Nottingham University Hospitals NHS Trust

OrganisationROR

Trials

  • NCT06462001

    Phase 3, Active, not recruiting, 500 people, 17 Jun 2024

  • NCT05663944

    Phase 2, Completed, 41 people, 23 Dec 2022

  • NCT03796156

    Collaborator, Phase 3, Terminated, 4,633 people, 8 Jan 2019

  • NCT02972723

    Phase 4, Completed, 16 people, 23 Nov 2016

  • NCT01913834

    Phase 1, Status unknown, 7 people, 1 Aug 2013

Grants and prizes

  • National Institute for Health and Care Research

    Research for Patient Benefit, Benefits and risks of pausing long-term osteoporosis treatment: nested case-control and cohort studies using data from the Clinical Practice Research Datalink., NIHR205348, £156.2k, 2024–2026, 1 Jan 2024

  • National Institute for Health and Care Research

    Efficacy and Mechanism Evaluation, A Multidisciplinary national research partnership for early diagnosis of liver disease in alcohol treatment programmes and the role of liver disease biomarker-based behavioural interventions in reducing alcohol-related harm., NIHR155469, £100.7k, 2023–2024, 1 Feb 2023

  • National Institute for Health and Care Research

    Research for Patient Benefit, WHiTE-LIT– World Hip Trauma Evaluation - Lidocaine Intravenous Trial: a feasibility study for a randomised controlled trial of the effect of intravenous lidocaine at the time of surgery on outcomes following hip fracture, NIHR201943, £249.7k, 2021–2024, 1 Aug 2021

  • National Institute for Health and Care Research

    NIHR Integrated Clinical and Practitioner Academic, Personalisation of exercise for people with dementia: What works for whom, under what circumstances and why?, NIHR300433, £188.7k, 2020–2023, 1 Apr 2020

  • National Institute for Health and Care Research

    Health Technology Assessment, The BLAST OFF (Bisphosphonate aLternAtive regimenS for the prevenTion of Osteoporotic Fragility Fractures) Study, NIHR127550, £490.5k, 2019–2022, 1 Oct 2019

  • National Institute for Health and Care Research

    Research for Patient Benefit, The ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation)- Randomised Controlled, Feasibility in Older People Trial. Short Title: The ASSERT Trial., PB-PG-0816-20002, £258k, 2018–2021, 3 Jul 2018

  • National Institute for Health and Care Research

    Programme Grants for Applied Research, Promoting Activity, Independence and Stability in Early Dementia (PrAISED), RP-PG-0614-20007, £3.1m, 2016–2023, 14 Mar 2016

Sources: fundingawards.nihr.ac.uk